FDA Authorizes New Oral Antiviral for COVID-19 Post-Exposure Prevention

The U.S. Food and Drug Administration has granted approval for ensitrelvir, an oral antiviral medication. This drug is intended for post-exposure prophylaxis of COVID-19 in individuals aged 12 and older. This decision introduces an additional option for preventing the virus after potential exposure.